10.1007/s00467-019-04377-6 [PubMed] [CrossRef] [Google Scholar] 30. eplet load, 64 (IQR 46C83) vs. 77 (IQR 56C98), p=0.012. The most common target of dnDSA were eplets expressed in HLA-A*11 and A2 in Class I, and HLA-DQ6 and DQA5 in Class II. The most commonly mismatched eplets were not the most likely to result in dnDSA formation. Conclusions: In a racially diverse population, only a subset of eplets were linked to antibody formation. Eplet load alone is not a sufficient surrogate for eplet immunogenicity. These findings illustrate the need to optimize precision in donor selection and allocation to improve long-term graft outcomes. Keywords: kidney transplant, pediatric, eplet mismatch, de novo DSA Graphical Abstract INTRODUCTION donor-specific antibodies (DSA) are deleterious to graft function and associated with a 7.34 ML604440 times increased risk for graft loss in pediatric kidney transplant recipients (KTR) [1, 2]. The ability of an HLA antigen to promote dnDSA development Mouse monoclonal to MDM4 hinges on the degree of variability in amino acid sequence between donor and recipient HLA, electrostatic charges resulting from interaction between HLA molecules of donor and recipient, and the level of expression of the HLA antigen [3]. Eplets are polymorphic 2C5 amino acid sequences in conformational structures within the larger 15C22 amino acid HLA epitope structure [4, 5]. They are shared among several HLA antigens, adding complexity and illustrating the lack of precision with direct serological comparison between donor and recipient. Eplet-based matching could identify acceptable mismatches among different HLA molecules and may help clinicians avoid specific mismatches that are more likely to result in dnDSA. Poorly matched allografts are at significantly increased risk for rejection and graft ML604440 failure which is especially impactful in pediatric patients who often need multiple transplants in their lifetime [6]. Eplet-based matching compared to antigen-level coordinating, has been suggested as a strategy to decrease dnDSA formation and thus lengthen allograft survival [7, 8]. Studies in adult and pediatric KTR have shown correlation of increasing eplet mismatch with dnDSA formation, chronic allograft nephropathy, graft failure and improved sensitization post allograft failure [9C12]. Studies have shown that restricting HLA-DR and HLA-DQ eplet mismatches below particular thresholds can reduce formation of dnDSA and therefore improve graft survival [13]. However, not all mismatches are equally immunogenic, with some clearly at higher risk for development of dnDSA. In a study in heart and lung transplant recipients, avoidance of HLA specificities expressing high-risk eplets was modeled to significantly reduce dnDSA formation thereby improving graft results without significantly increasing waitlist time [14]. This study was carried out in a racially standard human population of Canadian adult individuals. No studies possess sought to identify specific high-risk eplet mismatches inside a racially varied pediatric kidney transplant human population [15]. Given the importance of precise coordinating and allograft longevity in pediatric KTR, we wanted to investigate the association with eplet mismatches and dnDSA formation. We performed an exploratory analysis of a racially varied pediatric transplant cohort from a single center to increase our understanding of correlation between eplet mismatch and dnDSA formation, and therefore determine probably the most immunogenic eplet mismatches. METHODS Study human population We adopted 125 pediatric (< 21 at the time of transplant) main KTR who received transplant care in the Johns Hopkins Childrens Center between January 2006 and June 2017. Exclusion criteria included recipients of multi-organ transplant, earlier solid organ transplant, and pre-transplant DSA. An initial cohort of 144 individuals was recognized through the immunogenetics laboratory database. Subsequently, ML604440 12 were removed due to unavailable donor HLA data, and 7 were removed due to lack of medical data in the EMR. HLA typing and eplet analysis HLA typing was performed for recipients and donors at the time of transplantation using the LABType? opposite Sequence Specific oligonucleotide probe DNA typing (SSO One Lambda, Inc.). HLA alleles were entered into the Fusion version 4.2 which also features the HLA Matchmaker software (HLA-ABC version 02, upgrade June 2016 and HLA-DRDQDP (includes DR1/3/4/5, DQ1 and DP1), version 2.1, upgrade January 2017) to identify recipient-donor eplet mismatch weight. Eplets associated with dnDSA were recognized when the antibody cutoff was modified to > 3000 MFI in Fusion. When allele level data was not available or insufficiently defined from your.